Rachel Schneider is the founder and CEO of Canary, a New York fintech that lets employers and donors give tax-free emergency cash grants to workers in crisis. Before building software, she spent years studying how American families actually handle money - co-authoring the acclaimed book The Financial Diaries with economist Jonathan Morduch - and held senior roles at Merrill Lynch, the Aspen Institute, and the Financial Health Network. Canary turned that research into a product: a confidential application that moves money to people at the moment they need it most.
Sam Hodges is co-founder and CEO of Vouch Insurance, a tech-enabled insurance platform built specifically for high-growth startups and venture-backed companies. A serial fintech entrepreneur with 20+ years at the intersection of technology and financial services, Hodges previously co-founded and led the U.S. operations of Funding Circle to a 2018 London Stock Exchange IPO. He holds an MBA and MS from Stanford and a magna cum laude degree from Brown University, and is a Fellow of the inaugural Finance Leaders Fellowship at the Aspen Institute. Under his leadership, Vouch has raised over $229M in total funding, serves 6,000+ companies, and completed a Series D round in early 2025 alongside its acquisition of StartSure Insurance Services.

Abe Tarapani is the CEO of Atlas AI, a Palo Alto-based geospatial AI company that uses satellite imagery and machine learning to generate actionable insights on economic, agricultural, and infrastructure trends across emerging markets. A Yale-trained electrical engineer and Presidential Scholar recognized by the Clinton White House, Tarapani has spent nearly two decades at the intersection of renewable energy, data for development, and social impact. He joined Atlas AI in October 2020, steering a company founded by Stanford professors toward enterprise partnerships with the World Bank, DARPA, McKinsey, and Airbus, while earning recognition as a 2024 Google Cloud Partner of the Year and Gavi INFUSE Pacesetter.
Jorge Conde is a General Partner on the Bio + Health team at Andreessen Horowitz (a16z), where he invests at the intersection of biology, computer science, and engineering. Born in Miami to Cuban and Peruvian parents, Conde co-founded Knome — the first company to offer whole-genome sequencing directly to consumers — alongside Harvard geneticist George Church, then spent years as CSO, CFO, and CPO at Syros Pharmaceuticals before joining a16z in 2017. An MIT Technology Review Innovator Under 35 and Henry Crown Fellow at the Aspen Institute, he is one of the most prominent voices arguing that the 21st century belongs to biology the way the 20th belonged to physics.